Hep A
| Question | Evidence-Based, Logic-Driven Response (HepA) |
|---|---|
| What is my child’s actual risk of dying from this disease, statistically? | Hepatitis A is a mild, self-limiting viral illness in almost all children. In the U.S., asymptomatic or very mild in >90% of children under 6. Mortality in healthy children is statistically zero. Liver failure is exceedingly rare and typically occurs in older adults or those with preexisting liver disease. |
| Have you lost an unvaccinated child to Hep A? Any patients lost to the vaccine? | Doctors practicing today have never lost a healthy child to Hep A. In contrast, VAERS contains dozens of death reports, and many more of seizures, liver inflammation, and autoimmune reactions post-Hep A vaccination. |
| Odds of any side effect? Severe side effect? Compared to disease mortality? | - Mild: soreness, fever, loss of appetite (~15–20%). - Severe: autoimmune hepatitis, Guillain-Barré, seizures, anaphylaxis. - Death risk from wild virus in children: essentially zero. - Severe outcomes post-vaccine: documented, though rare and underreported. |
| Most severe adverse event you’ve seen? Most common? | Common: tiredness, low-grade fever. Severe: hepatic inflammation, seizures, immune system flare-ups, and fatal events in some infants post-vaccine. |
| Worst-case outcome from insert or VAERS? How many deaths reported? | VAERS: Over 100 deaths temporally associated with Hep A vaccine. Inserts list: anaphylaxis, encephalopathy, rash, autoimmune responses, death. Hepatitis A deaths in children pre-vaccine era: statistically negligible. |
| Recent VAERS reports? Severity? | Reports include sudden death, seizures, vomiting, immune reactions, fainting. Some children developed autoimmune conditions like lupus or liver damage post-vaccine. |
| How many VAERS reports have you filed? Do you follow up after administration? | Most pediatricians have never filed a VAERS report. Follow-up post-Hep A vaccination is rare unless an acute, dramatic event occurs within minutes or hours. |
| Will antibody testing be done before second dose? Why one-size-fits-all? | No titer is tested. Second dose is automatic per CDC, regardless of exposure, immunity, or health status. Many children already develop immunity after the first dose or through silent exposure. |
| Can you guarantee this vaccine will not cause immune or neurological damage? | No. The vaccine contains aluminum hydroxide, which has known neurotoxic effects in animal models, especially in neonates. Long-term autoimmune or cognitive outcomes have not been studied. |
| Was it tested against a true saline placebo? | No. Trials used non-saline comparators—either adjuvanted substances or unrelated vaccines. This invalidates true risk assessment. |
| Do you have unvaccinated patients? Ever advised skipping Hep A vaccine? | Very few doctors recommend skipping Hep A, even though the disease is mild or silent in almost all children. Schedule adherence typically overrides individual risk analysis. |
| If serious adverse events occur, do you continue with the second dose? | Unless the reaction is life-threatening and immediate, doctors often proceed. Delayed or chronic symptoms are rarely connected back to the vaccine. |
| Can we review the package insert and ingredients together? | HepA vaccines (Havrix, Vaqta) contain: inactivated virus, aluminum adjuvant, formaldehyde, neomycin traces. Adverse events listed: seizures, hypersensitivity, anaphylaxis, rash, fatigue, death. |
| How do you determine causation vs. coincidence? | Most providers dismiss symptoms unless they occur immediately and dramatically. Chronic symptoms (e.g., autoimmune disorders, fatigue, liver inflammation) are usually attributed to genetics or environment. |
| Any long-term studies comparing vaccinated vs. unvaccinated outcomes? | No. No study compares lifelong health outcomes of Hep A-vaccinated vs. unvaccinated children. No autoimmune or neurocognitive follow-up beyond 30–90 days post-vaccination. |
| Do you have concerns about the expanded CDC schedule? | Hep A was added in 2006–2007, despite being non-lethal in children. Its inclusion highlights a trend of medicalizing mild illnesses, raising concerns about pharmaceutical overreach. Doctors rarely question this. |
| Have you observed a rise in chronic inflammatory or autoimmune disorders? | Yes—IBD, thyroid disorders, eczema, asthma, PANS/PANDAS, and pediatric autoimmune syndromes have all risen. Early immune stimulation via vaccines is a biologically plausible contributor. |
| Would you acknowledge and report a serious adverse event if one occurred? | Most would not. Professional and legal concerns make doctors hesitant to connect dots, especially when the vaccine is assumed “safe” and the disease “preventable.” |
| Are you under pressure to vaccinate universally? | Yes. Insurance networks and quality control systems reward high compliance, and penalize deviation from the schedule. |
| Do you understand the vaccine injury compensation program? | Hep A-related injuries (autoimmune liver damage, death, seizures) have been compensated under VICP. Most parents are never informed of the program unless they push. |